Table 2.
C-reactive protein levels in children and adolescents with Duchenne muscular dystrophy during treatment with granulocyte-colony stimulating factor.
| Measurement | CRP (0-5.0) normal range | P value | ||
|---|---|---|---|---|
| Average | SD | |||
| Cycle 1 | 1 | 0.61 | 0.69 | NS |
| 2 | 0.41 | 0.42 | ||
|
| ||||
| Cycle 2 | 1 | 0.97 | 2.09 | NS |
| 2 | 1.09 | 2.34 | ||
|
| ||||
| Cycle 3 | 1 | 0.63 | 0.61 | NS |
| 2 | 1.17 | 1.46 | ||
|
| ||||
| Cycle 4 | 1 | 0.63 | 0.69 | NS |
| 2 | 0.60 | 0.51 | ||
|
| ||||
| Cycle 5 | 1 | 0.50 | 0.51 | NS |
| 2 | 0.50 | 0.55 | ||
CRP, C-reactive protein; NS, nonsignificant.